Loading data
HCAINasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 6.58 m USD | 40.94 m USD | 34.28 m USD | 20.96 m USD |
| Cost of revenue | 6.17 m USD | 35.23 m USD | 28.07 m USD | 12.38 m USD |
| Gross profit | 408.9 k USD | 5.72 m USD | 6.21 m USD | 8.58 m USD |
| Research and development expense | — | 378.79 k USD | 457.52 k USD | 434.91 k USD |
| Operating profit | -21.22 m USD | -78.14 k USD | 2.6 m USD | 6.37 m USD |
| Profit before tax | -43.34 m USD | -78.12 k USD | 2.02 m USD | 5.51 m USD |
| Income tax expense | 2.84 k USD | 322.41 k USD | 1.22 k USD | 1.81 k USD |
| Net income (reported basis) | -42.25 m USD | 1.5 m USD | 1.82 m USD | 4.2 m USD |
| Basic earnings per share | — | 0.05 USD/share | 0.07 USD/share | 0.18 USD/share |
| Diluted earnings per share | — | 0.05 USD/share | 0.07 USD/share | 0.18 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.